![](\"https:\/\/mms.businesswire.com\/media\/20260526403864\/en\/578868\/5\/spineguard-simple.jpg\")
<\/a><\/a>\nSpineGuard<\/b> (FR0011464452 - ALSGD), an innovative company that deploys its DSG\u00ae (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces that three new U.S. patent applications have received notices of allowance from the USPTO (United States Patent and Trademark Office).<\/p>
\nThe three recently allowed patent applications by the USPTO form part of a set of five patent families that SpineGuard has developed since 2017 through its efforts to integrate DSG technology into various surgical assistance platforms to secure the placement of orthopedic and dental implants. SpineGuard has already communicated about these patents as they progressed across different geographies, but the decisive milestone recently achieved is now full protection in the United States.<\/p>
\nThe first patent protects algorithms enabling a robot to automatically detect the imminent risk of a bone breach based on real-time variations in DSG electrical conductivity measurements of bone tissue. The second applies DSG to enhancing the safety of surgical navigation platforms by detecting deviations from the operative plan. The third protects different integration methods of the DSG sensor and its electrical connections within the drill bit and powered drill assembly used for bone drilling procedures.<\/p>
\nSt\u00e9phane Bette, Deputy CEO and cofounder of SpineGuard, stated<\/b>: \u201cThe SpineGuard team is proud to announce three newly granted patents that complete our protection in the United States, the world\u2019s leading market in our industry, on highly strategic value-creating aspects. In summary, the objective is to equip bone surgery assistance systems with in-situ, real-time feedback at the tip of their end-effector, thereby enhancing safety and expanding their range of applications. These advances in intellectual property confirm SpineGuard\u2019s commitment to continuing innovation and to properly protecting its unique solutions, enabling confident commercial deployment through strategic industrial partnerships.\u201d<\/i><\/p>
\nSince its foundation, SpineGuard has developed and maintained a significant IP portfolio currently including 11 patent families as well as 3 trademarks, in the major geographies such as Europe, USA, China and Japan.<\/p>
\nAbout SpineGuard\u00ae<\/b><\/p>
\nFounded in 2009 in France and the USA by Pierre J\u00e9r\u00f4me and St\u00e9phane Bette, SpineGuard is an innovative company deploying its proprietary radiation-free real time sensing technology DSG\u00ae (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices embedding its technology. Over 110,000 surgical procedures have been secured worldwide thanks to DSG\u00ae and 39 studies published in peer-reviewed scientific journals have demonstrated the multiple benefits DSG\u00ae offers to patients, surgeons, surgical staff and hospitals. Building on these strong fundamentals and several strategic partnerships, SpineGuard is expanding the scope of its DSG\u00ae technology to the treatment of scoliosis via anterior approach, sacroiliac joint fusion, dental implantology and innovations such as the \u00ab smart \u00bb pedicle screw and power drill or surgical robotics. DSG\u00ae was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer. SpineGuard has engaged in multiple ESG initiatives. For further information, visit www.spineguard.com<\/a><\/p> \nDisclaimer\n \nSpineGuard<\/b>